Immunoserv

Cardiff based biotechnology company ImmunoServ have devised kits for T cell testing that can indicate how protected people are from infectious diseases, such as COVID-19 and influenza.

Located at Cardiff Medicentre next to the University Hospital of Wales, they have established links to sell their kits worldwide.

The Immuno-T™ test uses tiny fragments of the virus or bacteria of interest to see if blood contains T cells that protect against the disease.

The blood test is able to monitor a person’s immune response after infection or vaccination. The world's first at-home COVID-19 Immuno-T™ test is available to anyone in the UK who wishes to test their own T cell immunity.

The company’s test can also measure immunity in large cohorts and population studies and enables standardised and scalable T cell testing to be performed in any laboratory throughout the world.

The scientists at ImmunoServ are experts in the T cell immunology field, with more than 100 publications measuring T cell responses to cancer, viruses and bacteria. ImmunoServ's expanding range of T cell testing products and services supports several public health bodies and research institutes providing significant insight into immunity to several diseases including COVID-19, seasonal flu, bird flu, group A strep, as well as improving the diagnosis and treatment of diseases such as multiple sclerosis and cancer.